ReWalk Personal Device Postmarket Study

计划入组 60 人 · 首次发布于 2016 年 10 月 26 日

Self-balancing Personal Exoskeleton for SCI

计划入组 24 人 · 首次发布于 2025 年 1 月 16 日

A Study Testing Safety and Tolerance of the ReWalk Exoskeleton Suit

计划入组 6 人 · 首次发布于 2008 年 2 月 29 日

Merional

seasonal influenza vaccine

HyperAcute Renal

ReWalk Robotics, Inc.

United States

ENERGIZER PERSONAL CARE LLC

United States

PERSONAL CARE INNOVATIONS PTY LTD

Australia

Lifeward Partners with CorLife to Expand Workers' Compensation Access to ReWalk Exoskeleton

FDA Grants 510(k) Clearance for ReWalk 7 Exoskeleton for Spinal Cord Injury Patients

Wandercraft Initiates Landmark Trial for Hands-Free Personal Exoskeleton in SCI Patients